These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27401840)

  • 1. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of neoadjuvant chemotherapy in the management of advanced ovarian yolk sac tumor.
    Lu Y; Yang J; Cao D; Huang H; Wu M; You Y; Chen J; Lang J; Shen K
    Gynecol Oncol; 2014 Jul; 134(1):78-83. PubMed ID: 24582864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian Yolk Sac Tumor: The Experience of a Regional Cancer Center.
    Wang X; Ma Z; Li Y
    Int J Gynecol Cancer; 2016 Jun; 26(5):884-91. PubMed ID: 27104939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Nov; 147(2):296-301. PubMed ID: 28803748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
    de La Motte Rouge T; Pautier P; Rey A; Duvillard P; Kerbrat P; Troalen F; Morice P; Haie-Meder C; Culine S; Lhommé C
    Eur J Cancer; 2011 Jan; 47(2):175-82. PubMed ID: 20851596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
    Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
    Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
    Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
    Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
    Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
    Inanç SE; Meral R; Darendeliler E; Yasasever V; Onat H
    Acta Oncol; 1999; 38(4):505-9. PubMed ID: 10418719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
    Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
    Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Yolk Sac Tumors; Does Age Matter?
    Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
    Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yolk sac tumor of the ovary during pregnancy: a case report.
    Aoki Y; Higashino M; Ishii S; Tanaka K
    Gynecol Oncol; 2005 Nov; 99(2):497-9. PubMed ID: 16051324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yolk sac tumor in a young girl: a case report.
    Razzi S; Luisi S; Gabbanini M; Lazzeri L; Mazzini M; Petraglia F
    Gynecol Endocrinol; 2005 Jun; 20(6):334-5. PubMed ID: 16019383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
    Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
    J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.